Global Cord Blood (NYSE:CO) Share Price Passes Above Two Hundred Day Moving Average - Here's What Happened

Key Points

• Global Cord Blood (NYSE: CO) crossed above its 200‑day moving average (200‑day MA $0.92), trading as high as $1.10 and rising about 4.8% on the session with 1,501 shares changing hands.
• Fundamentals and business: the company, a leading umbilical cord blood banking operator in China, has a market capitalization of $133.71 million, a P/E of 1.72 and a beta of 0.16.

Global Cord Blood Co. (NYSE:CO - Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.92 and traded as high as $1.10. Global Cord Blood shares last traded at $1.10, with a volume of 1,501 shares changing hands.

Global Cord Blood Stock Up 4.8%

The business has a fifty day simple moving average of $0.99 and a two-hundred day simple moving average of $0.92. The company has a market capitalization of $133.71 million, a price-to-earnings ratio of 1.72 and a beta of 0.16.

About Global Cord Blood

Global Cord Blood Corporation NYSE: CO is a leading operator of umbilical cord blood banking services in the People's Republic of China. The company provides critical stem cell preservation and related services through its network of cord blood banks and medical partners. Its core activities encompass the collection, processing, testing, and long-term storage of cord blood units, which are preserved for potential therapeutic use in the treatment of hematological and genetic disorders.

In addition to cord blood banking, Global Cord Blood offers supplemental clinical services such as viability testing, stem cell expansion research, and personalized consultation for expectant parents.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.